Clinical use of mood stabilizers beyond treatment for bipolar disorder: The REAP-MS study.
Chen CK, Yang SY, Park SC, Jang OJ, Zhu X, Xiang YT, Ouyang WC, Javed A, Khan MNS, Grover S, Avasthi A, Kallivayalil RA, Chee KY, Chemi N, Kato TA, Hayakawa K, Pariwatcharakul P, Maramis M, Seneviratne L, Sim K, Tang WK, Oo T, Sartorius N, Tan CH, Chong MY, Park YC, Shinfuku N, Lin SK.
Prenatal and perinatal risk and protective factors for psychosis: a systematic review and meta-analysis.
Davies C, Segre G, Estradé A, Radua J, De Micheli A, Provenzani U, Oliver D, Salazar de Pablo G, Ramella-Cravaro V, Besozzi M, Dazzan P, Miele M, Caputo G, Spallarossa C, Crossland G, Ilyas A, Spada G, Politi P, Murray RM, McGuire P, Fusar-Poli P.
Lancet Psychiatry. 2020 May;7(5):399-410. doi: 10.1016/S2215-0366(20)30057-2. Epub 2020 Mar 24.
PMID:32220288
Organic mood disorder: a valid psychiatry consultation diagnosis?